학술논문

Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2014, 32 4, 2p. Supplement: S
Subject
Language
English
ISSN
15277755